Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Payers
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
The Trump administration is weighing policies on expanding coverage to healthcare, but weight loss drugs are gaining more momentum than IVF services.
Noah Tong
Aug 4, 2025 2:50pm
Hims & Hers to offer generic semaglutide drugs in Canada
Jul 11, 2025 3:30pm
Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s
Feb 21, 2025 4:30pm
Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle
Feb 13, 2025 8:00am
New study finds 137M US adults are eligible for GLP-1s
Nov 25, 2024 4:00pm
Payer Roundup—Gov. Newsom vetoes PBM, private equity bills
Sep 30, 2024 2:40pm